Xiaoketongbi Formula vs pregabalin for painful diabetic neuropathy: A single-center, randomized, single-blind, double-dummy, and parallel controlled clinical trial.
Qiyun LuBenjian ChenQingshun LiangLiyan WuLulu LuoAnxiang LiWenwei OuyangZehuai WenYunwei LiuJiayan LuYunyi LiuGuanjie FanZhenjie LiuPublished in: Journal of diabetes (2022)
XF is equivalent to pregabalin in reducing pain symptoms and improves the quality of life in patients with PDN. In addition, XF has the potential to improve nerve function by increasing NCV.
Keyphrases
- neuropathic pain
- double blind
- clinical trial
- open label
- phase ii
- postoperative pain
- phase iii
- spinal cord
- placebo controlled
- spinal cord injury
- chronic pain
- type diabetes
- study protocol
- wound healing
- pain management
- human milk
- molecularly imprinted
- human health
- randomized controlled trial
- risk assessment
- mass spectrometry
- high resolution